Neoplasm Metastasis: all 3,564 studies
Page 1 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- An Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid TumorsNot yet recruitingNCT07893535Phase 1
- This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid TumorsRecruitingNCT07878988Phase 1
- Head-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in JapanNot yet recruitingNCT07870837Not applicable
- BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based TherapyRecruitingNCT07869836Phase 3
- Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate CancerRecruitingNCT07863986
- Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on TumorsNot yet recruitingNCT07863024Phase 1/2
- Blood Biomarkers for Breast Cancer Treatment ResponseNot yet recruitingNCT07860866
- Estimating the Impact of Sexuality Education and Mobile Health Services on Reproductive Health and Empowerment Among Adolescents in Sierra Leone for the Family Planning Impact LabNot yet recruitingNCT07860723Not applicable
- Labyrinthin Vaccination in Veterans With Lung AdenocarcinomaNot yet recruitingNCT07859592Phase 2
- Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal CancerNot yet recruitingNCT07856914Phase 2
- Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid TumorsRecruitingNCT07856394Not applicable
- A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma)RecruitingNCT07850882
- A Real-World Observational Study of Intratumoral H101 Oncolytic Adenovirus Combined With Immune Checkpoint Inhibitors for Advanced Metastatic Breast CancerRecruitingNCT07850869
- Change in Fat Fraction Quantification Before and After Treatment in Bone MetastasesNot yet recruitingNCT07848516
- First-line Treatment in Locally Advanced or Metastastic Small Bowel AdenocarcinomaNot yet recruitingNCT07844057Phase 2
- Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic CancerNot yet recruitingNCT07829185Phase 1
- The STRONG Nutrition Support Study for People With Pancreatic CancerNot yet recruitingNCT07826780Not applicable
- Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal CarcinomaNot yet recruitingNCT07824856Phase 2
- Prediction of Postoperative Recurrence in Crohn's DiseaseRecruitingNCT07824791
- A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease)RecruitingNCT07820644
- CREO - Microwave Ablation Feasibility StudyRecruitingNCT07817147Not applicable
- FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)RecruitingNCT07815834Phase 3
- Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment OptionsNot yet recruitingNCT07811453Not applicable
- Symptom Trajectory Approaches to ResearchNot yet recruitingNCT07804875
- Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With TebentafuspNot yet recruitingNCT07803562Phase 2
- Adding Capivasertib to Standard Treatment in HR Positive, HER2 Negative Metastatic Breast Cancer Based on ctDNA TestingNot yet recruitingNCT07802626Phase 3
- Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational StudyRecruitingNCT07799974
- Pelvic Floor Ultrasound Before Induction of Labour and Labour OutcomeNot yet recruitingNCT07797387
- Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract CancerNot yet recruitingNCT07793253Phase 2
- A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.RecruitingNCT07791745Phase 2/3
- The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07780578Phase 2
- Validation of the G8 Screening Tool for Prognostic Assessment of Frailty and Early Mortality in Elderly Individuals With Cancer: Prospective Cohort Study in BrazilNot yet recruitingNCT07773285
- Pemefolacianine for IMI of Lung CancerRecruitingNCT07772895Phase 1
- Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyNot yet recruitingNCT07762703Phase 1/2
- A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
- Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate CancerRecruitingNCT07751133Phase 3
- A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other Antitumor Agents in Patients With Advanced or Metastatic Solid Tumors With Rat Sarcoma Virus (RAS) MutationsRecruitingNCT07746141Phase 1
- Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath TumorNot yet recruitingNCT07743554Phase 2
- GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)Not yet recruitingNCT07738341Phase 1/2
- SLR-108 PET Imaging in Subjects With Metastatic Solid TumorsRecruitingNCT07728942Phase 1
- ML-016 in Advanced Cancer With Lung and/or Liver InvolvementRecruitingNCT07723482Phase 1/2
- Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 TrialRecruitingNCT07722754Phase 2
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 1
- Addition of Platinum-based Chemotherapy to Tislelizumab in PD-L1high Metastatic Non-small Cell Lung Cancer With a High Tumor BurdenNot yet recruitingNCT07715396Phase 3
- A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Pancreatic CancerRecruitingNCT07701486Phase 1/2
- Pluvicto Real-world Investigation in Survival in Metastatic CRPCNot yet recruitingNCT07697989
- Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort StudyRecruitingNCT07696832
- A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal CancerRecruitingNCT07693751Phase 1/2
- A Study of Combination Therapy in Patients With Resectable Liver CancerNot yet recruitingNCT07684040Phase 2
- Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and NeckNot yet recruitingNCT07682675Phase 2
- First-in-Human Trial of DS1025a in Participants With Advanced Solid TumorsRecruitingNCT07681882Phase 1
- An Experimental Study of Belzutifan Impact on Catecholamine MetabolismRecruitingNCT07680205Phase 2
- Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid TumorsAvailableNCT07675057
- Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy DeliveryNot yet recruitingNCT07674771Early Phase 1
- Tisotumab Vedotin in Squamous Cell Carcinoma of the VulvaNot yet recruitingNCT07672782Phase 2
- Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT TrialNot yet recruitingNCT07671768Not applicable
- Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLCNot yet recruitingNCT07671560Phase 4
- Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic CancerNot yet recruitingNCT07665684Phase 1/2
- A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck CancerNot yet recruitingNCT07662720Phase 1/2
- CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaRecruitingNCT07659678Phase 2
- Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal DiseaseNot yet recruitingNCT07659652
- Pilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric PatientsNot yet recruitingNCT07658768Early Phase 1
- TLR9 Immunotherapy for Peritoneal CarcinomatosisRecruitingNCT07658196Phase 1
- A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast CancerRecruitingNCT07658183Phase 2
- Inhaled mRNA Immunotherapy for Patients With Advanced Lung Cancer or Pulmonary Metastatic Solid TumorsNot yet recruitingNCT07657611Early Phase 1
- A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast CancerRecruitingNCT07653893
- A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerRecruitingNCT07647328Phase 3
- Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLCRecruitingNCT07641023Phase 1/2
- FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor CancersRecruitingNCT07638371Phase 1
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceRecruitingNCT07636148
- A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.Not yet recruitingNCT07635524Phase 2
- Decision Support Tool for Patients With Advanced Breast CancerRecruitingNCT07635147Not applicable
- Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid TumorNot yet recruitingNCT07631884Phase 2
- A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsRecruitingNCT07629960Phase 1/2
- Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaRecruitingNCT07627711Phase 1/2
- A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT07621601Phase 3
- IL-15 Enhanced NK Cell Therapy for Solid TumorsRecruitingNCT07621471Early Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid TumorRecruitingNCT07612891Phase 1/2
- A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid TumorsRecruitingNCT07612176Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D MutationsRecruitingNCT07610798Phase 1/2
- Xiaochaihu Granules for Depression After Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07608029Phase 2
- A Study of IDP-001 in Advanced or Metastatic Solid TumorsRecruitingNCT07602842Phase 1/2
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP DeletionRecruitingNCT07594626Phase 1/2
- Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.RecruitingNCT07594431Phase 2
- Prospective Clinical Database Construction for Liver Cancer Diagnosis and TreatmentRecruitingNCT07587216
- Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid TumorsRecruitingNCT07584499Phase 1
- Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid TumorsNot yet recruitingNCT07583914Phase 1
- Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid TumorsRecruitingNCT07583654Phase 1
- A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid TumorsNot yet recruitingNCT07583316Phase 1
- Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT07581821Phase 2
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.RecruitingNCT07572760Not applicable
- NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor MalignanciesRecruitingNCT07563829Phase 1
- A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLCRecruitingNCT07562581Phase 2
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruitingNCT07562152Phase 3
- Remote Monitoring and Symptom Management Digital ApplicationRecruitingNCT07553572Not applicable
- Identification of Therapeutic Targets in Metastatic Gastric CancerRecruitingNCT07551440
- A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadRecruitingNCT07543055Phase 1
- Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid CancersRecruitingNCT07540650Phase 2
- Surgery Plus Systemic Therapy for Liver Cancer With Extrahepatic MetastasesNot yet recruitingNCT07537959Not applicable